Clinical Trial Update: HCT With PTCy in Higher-risk MDS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in higher-risk myelodysplastic syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia Evolving From Myelodysplastic Syndromes
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• HCT with PTCy
• PTCy (post-transplant cyclophosphamide)

Snippet

Sponsor: Asan Medical Center | Conditions: Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) | Phase 2 | Status: ACTIVE_NOT_RECRUITING